185 related articles for article (PubMed ID: 31030373)
1. Exosomes, metastases, and the miracle of cancer stem cell markers.
Wang Z; Zöller M
Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
[TBL] [Abstract][Full Text] [Related]
3. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
[TBL] [Abstract][Full Text] [Related]
4. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
6. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
[TBL] [Abstract][Full Text] [Related]
7. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
Sun H; Rana S; Wang Z; Zhao K; Schnölzer M; Provaznik J; Hackert T; Lv Q; Zöller M
J Oncol; 2019; 2019():3516973. PubMed ID: 31485223
[TBL] [Abstract][Full Text] [Related]
8. CD44 and EpCAM: cancer-initiating cell markers.
Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
[TBL] [Abstract][Full Text] [Related]
9. Exosomes in Cancer Disease.
Zöller M
Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
[TBL] [Abstract][Full Text] [Related]
10. Tspan8 and Tspan8/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression.
Zhao K; Wang Z; Hackert T; Pitzer C; Zöller M
J Exp Clin Cancer Res; 2018 Dec; 37(1):312. PubMed ID: 30541597
[TBL] [Abstract][Full Text] [Related]
11. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
Yue S; Mu W; Erb U; Zöller M
Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
[TBL] [Abstract][Full Text] [Related]
12. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
Mu W; Wang Z; Zöller M
Front Oncol; 2019; 9():1359. PubMed ID: 31921628
[TBL] [Abstract][Full Text] [Related]
13. Outsmart tumor exosomes to steal the cancer initiating cell its niche.
Thuma F; Zöller M
Semin Cancer Biol; 2014 Oct; 28():39-50. PubMed ID: 24631836
[TBL] [Abstract][Full Text] [Related]
14. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
Massoumi RL; Hines OJ; Eibl G; King JC
Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
[TBL] [Abstract][Full Text] [Related]
15. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
Wang H; Rana S; Giese N; Büchler MW; Zöller M
Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
[TBL] [Abstract][Full Text] [Related]
16. Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery.
Erb U; Zhao K; Wang Z; Xiao L; Zöller M
Cancer Lett; 2017 Sep; 403():1-12. PubMed ID: 28619525
[TBL] [Abstract][Full Text] [Related]
17. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
Wang Z; Zhao K; Hackert T; Zöller M
Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
[TBL] [Abstract][Full Text] [Related]
18. Roles of exosomes in metastatic colorectal cancer.
Lafitte M; Lecointre C; Roche S
Am J Physiol Cell Physiol; 2019 Nov; 317(5):C869-C880. PubMed ID: 31291143
[TBL] [Abstract][Full Text] [Related]
19. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
[TBL] [Abstract][Full Text] [Related]
20. Progress and potential of exosome analysis for early pancreatic cancer detection.
Erb U; Zöller M
Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]